CLINICAL_TRIALS
ClinicalTrials.gov record update
GLOBAL PREVALENCE OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN PARTICIPANTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04424914
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:22.100196+00:00
- Published At
- 2024-07-19T00:00:00+00:00
- Record Updated At
- 2024-07-19
- Results Posted At
- 2024-07-19
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Transthyretin Amyloid Cardiomyopathy", "Heart Failure With Preserved Ejection Fraction"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-19"- protocolSection.identificationModule.nctId
"NCT04424914"- protocolSection.identificationModule.officialTitle
"GLOBAL PREVALENCE OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN PARTICIPANTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-07-19"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.